AMP publishes curriculum recommendations for medical laboratory scientists

The Association for Molecular Pathology (AMP) released a report today in The Journal of Molecular Diagnostics on recommendations for a molecular diagnostics curriculum at both the baccalaureate and master's levels of education. The report was prepared by the Medical Laboratory Scientist (MLS) Curriculum Task Force of the AMP Training and Education Committee. "Our goal was to address the critical need of educating future medical laboratory scientists appropriately in order to manage the rapidly growing and changing realm of molecular diagnostic testing," said Sara Taylor, PhD, Task Force Co-Chair and a first author on the paper.

The challenge, as stated in the report, is to balance the requirements of accreditation, certification, and the needs of the job market. To address that challenge, the recommendations are based on input from three key elements: 1) the National Accrediting Agency for Clinical Laboratory Sciences (NAACLS) guidelines for accreditation of programs; 2) guidelines of several key certifying bodies for clinical laboratory scientists; and, 3) feedback from current employers of molecular diagnostics scientists via a survey of AMP members.

In addition, the curriculum recommendations are directed towards three major academic levels of laboratory scientists who perform molecular diagnostic testing - the generalist MLS/CLS, and both the bachelors and masters-level lab scientists with specialized molecular training.

AMP concludes that up-and-coming molecular diagnostic laboratory scientists should complete an NAACLS accredited training program, then become certified or licensed in their state of employment. The specific curriculum recommendations, if adopted, will prepare tomorrow's medical laboratory scientists for the reality that molecular diagnostics are an integral and growing part of the clinical diagnostic laboratory.

"As the organization that is home to all molecular diagnostic professionals, AMP has a responsibility to help guide the training for future molecular technologists," said Elaine Lyon, PhD, AMP President. "The demand for specially-trained scientists who are capable of performing high complexity testing is growing. The set forth by the MLS Task Force will help to support the rapid advances in genomic technology and techniques."

More information: dx.doi.org/10.1016/j.jmoldx.2014.02.003

add to favorites email to friend print save as pdf

Related Stories

AMP releases statement on diagnostics in drug labels

May 16, 2011

Today, the Association for Molecular Pathology (AMP) released its new position statement on the appropriate manner to reference diagnostic tests in drug labels. The association also met with officials from the United States ...

Recommended for you

Cold cash just keeps washing in from ALS challenge

3 hours ago

In the couple of hours it took an official from the ALS Association to return a reporter's call for comment, the group's ubiquitous "ice bucket challenge" had brought in a few million more dollars.

Medtronic spends $350M on another European deal

19 hours ago

U.S. medical device maker Medtronic is building stronger ties to Europe, a couple months after announcing a $42.9 billion acquisition that involves moving its main executive offices across the Atlantic, where it can get a ...

Mind over matter for people with disabilities

Aug 26, 2014

People with serious physical disabilities are unable to do the everyday things that most of us take for granted despite having the will – and the brainpower – to do so. This is changing thanks to European ...

Ukraine's former world's tallest man dies

Aug 25, 2014

Ukraine's tallest man, who briefly held the world record but gave it up to live as a recluse, has died due to complications from the condition that saw him never stop growing, local media reported Monday.

User comments